BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Too NSH, Ho NCW, Adine C, Iyer NG, Fong ELS. Hot or cold: Bioengineering immune contextures into in vitro patient-derived tumor models. Adv Drug Deliv Rev 2021;175:113791. [PMID: 33965462 DOI: 10.1016/j.addr.2021.05.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Guo B, Liu X, Zhang J, Zhang J, Fang Y, Zhu S, Wei B, Cao Y, Zhan L. Roles of N6-methyladenosine (m6A) modifications in gynecologic cancers: mechanisms and therapeutic targeting. Exp Hematol Oncol 2022;11:98. [DOI: 10.1186/s40164-022-00357-z] [Reference Citation Analysis]
2 Dong Y, Zhao Z, Simayi M, Chen C, Xu Z, Lv D, Tang B. Transcriptome profiles of fatty acid metabolism-related genes and immune infiltrates identify hot tumors for immunotherapy in cutaneous melanoma. Front Genet 2022;13:860067. [DOI: 10.3389/fgene.2022.860067] [Reference Citation Analysis]
3 Ning Y, Lin K, Liu X, Ding Y, Jiang X, Zhang Z, Xuan Y, Dong L, Liu L, Wang F, Zhao Q, Wang H, Fang J. NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02475-8] [Reference Citation Analysis]
4 Yang Y, Zhao T, Chen Q, Li Y, Xiao Z, Xiang Y, Wang B, Qiu Y, Tu S, Jiang Y, Nan Y, Huang Q, Ai K. Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC. Advanced Science. [DOI: 10.1002/advs.202202797] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Shen R, Peng L, Zhou W, Wang D, Jiang Q, Ji J, Hu F, Yuan H. Anti-angiogenic nano-delivery system promotes tumor vascular normalizing and micro-environment reprogramming in solid tumor. J Control Release 2022;349:550-64. [PMID: 35841997 DOI: 10.1016/j.jconrel.2022.07.015] [Reference Citation Analysis]
6 Wang L, Sun X, He J, Liu Z. Identification and Validation of Prognostic Related Hallmark ATP-Binding Cassette Transporters Associated With Immune Cell Infiltration Patterns in Thyroid Carcinoma. Front Oncol 2022;12:781686. [DOI: 10.3389/fonc.2022.781686] [Reference Citation Analysis]
7 Zhang J, Tavakoli H, Ma L, Li X, Han L, Li X. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment. Adv Drug Deliv Rev 2022;187:114365. [PMID: 35667465 DOI: 10.1016/j.addr.2022.114365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Fong ELS, Iyer NG. Next generation in vitro tumor models guiding cancer therapy. Adv Drug Deliv Rev 2021;179:114047. [PMID: 34763000 DOI: 10.1016/j.addr.2021.114047] [Reference Citation Analysis]
9 Xu F, Liu T, Zhou Z, Zou C, Xu S. Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer. Front Immunol 2021;12:749369. [PMID: 34745121 DOI: 10.3389/fimmu.2021.749369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]